Advertisement

Inpharma Weekly

, Volume 1349, Issue 1, pp 7–9 | Cite as

Gefitinib shows promise in NSCLC

Meeting report
  • 4 Downloads

Keywords

Epidermal Growth Factor Receptor Gefitinib Ideal Study Iressa Median Survival Duration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Adis International Ltd 2002

Personalised recommendations